CCR6 and myeloid sarcoma: Additionally, our findings showed a strong correlation between CSF CXCL13 and CCL20, supporting the theory that CCL20–CCR6 interactions promote CXCL13 production, which subsequently recruits B lymphocytes during early MS pathogenesis [19].